Teva Pharmaceutical Industries Ltd (TEVA.O)
52.91USD
18 Dec 2009
$0.44 (+0.84%)
$52.47
$52.58
$53.27
$52.40
8,230,835
4,490,325
$54.95
$41.05
TEVA.O
About
Overall
| Beta: | 0.26 |
| Market Cap (Mil.): | $180,266.20 |
| Shares Outstanding (Mil.): | 889.00 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| TEVA.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 58.07 | 3.54 | 4.61 |
| EPS (TTM): | -59.27 | -- | -- |
| ROI: | 4.18 | 1.79 | 2.83 |
| ROE: | 5.47 | 2.40 | 3.59 |
UPDATE 2-AstraZeneca fails to win judgment in Crestor case
* Company remains confident on patents for blockbuster drug
EU raids pharmas over suspected abuse
BRUSSELS (Reuters) - European Union antitrust authorities said on Wednesday they had raided several pharmaceutical companies in a number of EU member states on suspicion of abusing a dominant position in the market.
Potential Ratiopharm bidders drop out-sources
FRANKFURT, Dec 9 (Reuters) - A strategic player looks set to clinch Ratiopharm after a raft of private equity bidders dropped out of the race to bid for the German generic drugs maker, sources familiar with the matter said Wednesday.
UPDATE 1-EU raids pharma firms over suspected abuse
* European Commission continues crackdown on pharma sector
UPDATE 2-Amgen sets new buyback of underperforming shares
* Says new buyback plan on top of earlier one (Adds details on company challenges, opportunities, byline)
Ratiopharm gets higher offers, to winnow bidders
LONDON/FRANKFURT, Dec 4 (Reuters) - The owners of German generic drugmaker Ratiopharm will soon pick a smaller group of suitors for detailed talks after receiving improved offers from about a dozen suitors, two people familiar with the matter said. The owners, the family of late German billionaire Adolf Merckle, had hoped to raise as much as 3.5 billion euros ($5.3 billion). However, sources close to the proceedings said when initial bids were filed in early November that they were mostly betwe
UPDATE 4-Pfizer acquires rights to Protalix's Gaucher drug
* Protalix eligible to milestone payments of up to $55 mln
UPDATE 1-Teva seeks FDA nod for biosimilar of Amgen drug
NEW YORK, Dec 1 (Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd said on Tuesday it is seeking U.S. approval to market a biotechnology medicine to boost white blood cells that is similar to Amgen Inc's big-selling Neupogen.
UPDATE 1-Pfizer to launch generic drugs in Japan
* Says to start selling generic drugs in Japan after 2010
Pfizer says to start selling generic drugs in Japan
TOKYO, Dec 1 (Reuters) - Pfizer Inc , the world's largest drugmaker, plans to start selling generic drugs in Japan, the head of its Japan unit said on Tuesday.
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
